{"id":"https://openalex.org/W2052275340","doi":"https://doi.org/10.1182/blood-2002-06-1793","title":"Radioimmunotherapy of non-Hodgkin lymphomas","display_name":"Radioimmunotherapy of non-Hodgkin lymphomas","publication_year":2002,"publication_date":"2002-12-31","ids":{"openalex":"https://openalex.org/W2052275340","doi":"https://doi.org/10.1182/blood-2002-06-1793","mag":"2052275340","pmid":"https://pubmed.ncbi.nlm.nih.gov/12393555"},"language":"en","primary_location":{"id":"doi:10.1182/blood-2002-06-1793","doi":"https://doi.org/10.1182/blood-2002-06-1793","is_oa":false,"landing_page_url":"https://doi.org/10.1182/blood-2002-06-1793","pdf_url":null,"source":{"id":"https://openalex.org/S200071133","display_name":"Blood","issn_l":"0006-4971","issn":["0006-4971","1528-0020"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Blood","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W2052275340"],"child_works_count":0,"type":"review","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5082606841","display_name":"Bruce D. Cheson","orcid":"https://orcid.org/0000-0001-9255-7655","observed_orcids":["https://orcid.org/0000-0001-9255-7655","https://orcid.org/0000-0002-6246-4308"]},"institutions":[{"id":"https://openalex.org/I184565670","display_name":"Georgetown University","ror":"https://ror.org/05vzafd60","country_code":"US","type":"education","lineage":["https://openalex.org/I184565670"]},{"id":"https://openalex.org/I2799903593","display_name":"Georgetown University Medical Center","ror":"https://ror.org/00hjz7x27","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I2799903593"]},{"id":"https://openalex.org/I4390039356","display_name":"Georgetown Lombardi Comprehensive Cancer Center","ror":"https://ror.org/035zrb927","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I184565670","https://openalex.org/I4390039356"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Bruce D. Cheson","raw_affiliation_strings":["From the Georgetown University Hospital, Lombardi Cancer Center, Washington, DC","Georgetown University Hospital, Lombardi Cancer Center, Washington, DC 20007, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"From the Georgetown University Hospital, Lombardi Cancer Center, Washington, DC","institution_ids":["https://openalex.org/I184565670","https://openalex.org/I2799903593","https://openalex.org/I4390039356"]},{"raw_affiliation_string":"Georgetown University Hospital, Lombardi Cancer Center, Washington, DC 20007, USA","institution_ids":["https://openalex.org/I184565670","https://openalex.org/I2799903593","https://openalex.org/I4390039356"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":3,"corresponding_author_ids":["https://openalex.org/A5082606841"],"corresponding_institution_ids":["https://openalex.org/I184565670","https://openalex.org/I2799903593","https://openalex.org/I4390039356"],"apc_list":{"value":5500,"currency":"USD","value_usd":5500},"apc_paid":null,"fwci":3.1712,"has_fulltext":false,"cited_by_count":183,"citation_normalized_percentile":{"value":0.93220339,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":93,"max":99},"biblio":{"volume":"101","issue":"2","first_page":"391","last_page":"398"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11395","display_name":"Radiopharmaceutical Chemistry and Applications","score":0.9639000296592712,"subfield":{"id":"https://openalex.org/subfields/2741","display_name":"Radiology, Nuclear Medicine and Imaging"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11395","display_name":"Radiopharmaceutical Chemistry and Applications","score":0.9639000296592712,"subfield":{"id":"https://openalex.org/subfields/2741","display_name":"Radiology, Nuclear Medicine and Imaging"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10185","display_name":"Lymphoma Diagnosis and Treatment","score":0.03269999846816063,"subfield":{"id":"https://openalex.org/subfields/2734","display_name":"Pathology and Forensic Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11157","display_name":"Chronic Lymphocytic Leukemia Research","score":0.0005000000237487257,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/radioimmunotherapy","display_name":"radioimmunotherapy","score":0.9990000128746033},{"id":"https://openalex.org/keywords/non-hodgkin-lymphoma","display_name":"non-Hodgkin lymphoma","score":0.9990000128746033},{"id":"https://openalex.org/keywords/yttrium-90-ibritumomab-tiuxetan","display_name":"yttrium-90 ibritumomab tiuxetan","score":0.9490000009536743},{"id":"https://openalex.org/keywords/iodine-131-tositumomab","display_name":"iodine-131 tositumomab","score":0.9919999837875366},{"id":"https://openalex.org/keywords/rituximab","display_name":"rituximab","score":0.9210000038146973},{"id":"https://openalex.org/keywords/monoclonal-antibodies","display_name":"monoclonal antibodies","score":0.7170000076293945},{"id":"https://openalex.org/keywords/targeted-radiotherapy","display_name":"targeted radiotherapy","score":0.7409999966621399},{"id":"https://openalex.org/keywords/myelosuppression","display_name":"myelosuppression","score":0.8299999833106995},{"id":"https://openalex.org/keywords/myelodysplastic-syndrome","display_name":"myelodysplastic syndrome","score":0.9940000176429749},{"id":"https://openalex.org/keywords/acute-myeloid-leukemia","display_name":"acute myeloid leukemia","score":0.7609999775886536},{"id":"https://openalex.org/keywords/relapsed-refractory-lymphoma","display_name":"relapsed/refractory lymphoma","score":0.703000009059906}],"concepts":[{"id":"https://openalex.org/C2776146153","wikidata":"https://www.wikidata.org/wiki/Q7281276","display_name":"Radioimmunotherapy","level":4,"score":0.969399631023407},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.8457912802696228},{"id":"https://openalex.org/C2778515704","wikidata":"https://www.wikidata.org/wiki/Q635415","display_name":"Ibritumomab tiuxetan","level":5,"score":0.7687662243843079},{"id":"https://openalex.org/C2780653079","wikidata":"https://www.wikidata.org/wiki/Q412323","display_name":"Rituximab","level":3,"score":0.7327625751495361},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.5745131969451904},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.5337105393409729},{"id":"https://openalex.org/C2779338263","wikidata":"https://www.wikidata.org/wiki/Q208414","display_name":"Lymphoma","level":2,"score":0.5002732276916504},{"id":"https://openalex.org/C542903549","wikidata":"https://www.wikidata.org/wiki/Q422248","display_name":"Monoclonal antibody","level":3,"score":0.39425039291381836},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.2890419661998749},{"id":"https://openalex.org/C159654299","wikidata":"https://www.wikidata.org/wiki/Q79460","display_name":"Antibody","level":2,"score":0.1866130232810974}],"mesh":[{"descriptor_ui":"D000911","descriptor_name":"Antibodies, Monoclonal","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D000911","descriptor_name":"Antibodies, Monoclonal","qualifier_ui":"Q000633","qualifier_name":"toxicity","is_major_topic":false},{"descriptor_ui":"D002986","descriptor_name":"Clinical Trials as Topic","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008228","descriptor_name":"Lymphoma, Non-Hodgkin","qualifier_ui":"Q000532","qualifier_name":"radiotherapy","is_major_topic":true},{"descriptor_ui":"D016499","descriptor_name":"Radioimmunotherapy","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":true},{"descriptor_ui":"D016499","descriptor_name":"Radioimmunotherapy","qualifier_ui":"Q000379","qualifier_name":"methods","is_major_topic":true},{"descriptor_ui":"D016879","descriptor_name":"Salvage Therapy","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":3,"locations":[{"id":"doi:10.1182/blood-2002-06-1793","doi":"https://doi.org/10.1182/blood-2002-06-1793","is_oa":false,"landing_page_url":"https://doi.org/10.1182/blood-2002-06-1793","pdf_url":null,"source":{"id":"https://openalex.org/S200071133","display_name":"Blood","issn_l":"0006-4971","issn":["0006-4971","1528-0020"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Blood","raw_type":"journal-article"},{"id":"pmid:12393555","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/12393555","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Blood","raw_type":"Journal Article"},{"id":"pmh:oai:CiteSeerX.psu:10.1.1.1004.9265","doi":null,"is_oa":false,"landing_page_url":"http://citeseerx.ist.psu.edu/viewdoc/summary?doi=10.1.1.1004.9265","pdf_url":null,"source":null,"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"http://www.bloodjournal.org/content/bloodjournal/101/2/391.full.pdf?sso-checked%3Dtrue","raw_type":"text"}],"best_oa_location":null,"sustainable_development_goals":[{"score":0.98580002784729,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":55,"referenced_works":["https://openalex.org/W147398146","https://openalex.org/W1484629663","https://openalex.org/W1485533072","https://openalex.org/W1558352531","https://openalex.org/W1568172327","https://openalex.org/W1573890015","https://openalex.org/W1603051829","https://openalex.org/W1628263893","https://openalex.org/W1781153995","https://openalex.org/W1869307723","https://openalex.org/W1892026381","https://openalex.org/W1915689252","https://openalex.org/W1931731730","https://openalex.org/W1933173754","https://openalex.org/W1940241583","https://openalex.org/W1940470585","https://openalex.org/W2007734777","https://openalex.org/W2014707443","https://openalex.org/W2018742207","https://openalex.org/W2044556240","https://openalex.org/W2066610908","https://openalex.org/W2080416356","https://openalex.org/W2084493022","https://openalex.org/W2097523533","https://openalex.org/W2107466475","https://openalex.org/W2107990794","https://openalex.org/W2110422885","https://openalex.org/W2110646221","https://openalex.org/W2112557828","https://openalex.org/W2118833600","https://openalex.org/W2135157531","https://openalex.org/W2146408325","https://openalex.org/W2164532418","https://openalex.org/W2184174775","https://openalex.org/W2185806117","https://openalex.org/W2200499915","https://openalex.org/W2229923863","https://openalex.org/W2256690185","https://openalex.org/W2264636885","https://openalex.org/W2267583049","https://openalex.org/W2472296897","https://openalex.org/W2605539363","https://openalex.org/W2618238976","https://openalex.org/W2626851375","https://openalex.org/W3193888120","https://openalex.org/W3194264583","https://openalex.org/W3196031715","https://openalex.org/W3196448665","https://openalex.org/W4205736005","https://openalex.org/W4238733764","https://openalex.org/W6633732806","https://openalex.org/W6636542757","https://openalex.org/W6677680400","https://openalex.org/W6684231579","https://openalex.org/W6686738645"],"related_works":["https://openalex.org/W2030984783","https://openalex.org/W1535153525","https://openalex.org/W2019444085","https://openalex.org/W2466374080","https://openalex.org/W2026983161","https://openalex.org/W2154167231","https://openalex.org/W2049951799","https://openalex.org/W2071174000","https://openalex.org/W2024642244"],"abstract_inverted_index":{"Enthusiasm":[0],"for":[1],"the":[2,13,50,105],"use":[3],"of":[4,31,65,89,107],"monoclonal":[5],"antibodies,":[6],"such":[7],"as":[8,28],"rituximab,":[9],"has":[10,71],"markedly":[11],"changed":[12],"approach":[14],"to":[15,38,73,75,102],"patients":[16,68],"with":[17,85],"non-Hodgkin":[18],"lymphomas":[19],"(NHLs).":[20],"Nevertheless,":[21],"more":[22],"effective":[23],"therapies":[24],"are":[25,100],"needed.":[26],"Radioimmunotherapy":[27],"a":[29,62,86],"form":[30],"targeted":[32],"radiation":[33],"therapy":[34],"may":[35],"add":[36],"significantly":[37],"our":[39],"therapeutic":[40],"options.":[41],"Yttrium":[42],"Y":[43],"90":[44],"ibritumomab":[45],"tiuxetan,":[46],"recently":[47],"approved":[48],"by":[49],"Food":[51],"and":[52,55,77,93],"Drug":[53],"Administration,":[54],"iodine":[56],"I":[57],"131":[58],"tositumomab":[59],"have":[60,80],"demonstrated":[61],"high":[63],"level":[64],"activity":[66],"in":[67],"whose":[69],"NHL":[70],"failed":[72],"respond":[74],"chemotherapy":[76],"rituximab.":[78],"Toxicities":[79],"primarily":[81],"included":[82],"prolonged":[83],"myelosuppression,":[84],"potential":[87],"risk":[88],"treatment-associated":[90],"myelodysplastic":[91],"syndrome":[92],"acute":[94],"myelogenous":[95],"leukemia.":[96],"Ongoing":[97],"clinical":[98],"trials":[99],"attempting":[101],"better":[103],"characterize":[104],"role":[106],"these":[108],"promising":[109],"agents.":[110]},"counts_by_year":[{"year":2026,"cited_by_count":2},{"year":2022,"cited_by_count":3},{"year":2021,"cited_by_count":4},{"year":2020,"cited_by_count":2},{"year":2019,"cited_by_count":5},{"year":2018,"cited_by_count":3},{"year":2017,"cited_by_count":3},{"year":2016,"cited_by_count":4},{"year":2015,"cited_by_count":7},{"year":2014,"cited_by_count":6},{"year":2013,"cited_by_count":2},{"year":2012,"cited_by_count":5}],"updated_date":"2026-11-14T11:04:58.165337","created_date":"2016-06-24T00:00:00"}
